HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated n-alkanes in congenital ichthyosiform erythroderma. Phenotypic differentiation of two types of autosomal recessive ichthyosis.

Abstract
Previously considered to represent a single genetic disorder, autosomal recessive ichthyosis was examined in clinical and lipid biochemical studies of 18 patients with this condition and instead disclosed to be two distinct diseases. Six patients displayed clinical features of classical lamellar ichthyosis (LI), which is characterized by monomorphous features, including large, dark, platelike scales, severe ectropion, and a uniformly severe, unremitting course. 11 patients displayed clinical features of nonbullous congenital ichthyosiform erythroderma (CIE) characterized by fine white scales, prominent erythroderma, a milder course, and a variable prognosis. CIE could be separated biochemically from LI by the invariable presence of elevated quantities of n-alkanes in scale (CIE, 24.8 +/- 1.9% vs. LI, 7.2 +/- 1.6%, and normal, 6.5 +/- 0.9%), which suggested a primary disorder in neutral lipid metabolism. In light of the distinctive clinical features of each, these biochemical studies indicate that autosomal recessive ichthyosis comprises two distinct disorders.
AuthorsM L Williams, P M Elias
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 74 Issue 1 Pg. 296-300 (Jul 1984) ISSN: 0021-9738 [Print] United States
PMID6736251 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Alkanes
  • Fatty Acids, Nonesterified
  • Lipids
  • Sphingolipids
  • Sterols
  • Triglycerides
Topics
  • Alkanes (analysis)
  • Chromatography, Thin Layer
  • Fatty Acids, Nonesterified (analysis)
  • Genes, Recessive
  • Humans
  • Ichthyosis (diagnosis, genetics, pathology)
  • Lipids (analysis)
  • Phenotype
  • Reference Values
  • Skin (analysis, pathology)
  • Sphingolipids (analysis)
  • Sterols (analysis)
  • Triglycerides (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: